Azelis stock: Results arrive October 22 after revenue rose 3.20 percent

Published on 10/21/2026 at 15:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results arrive October 22 after EUR 2.2 billion first-half revenue. Azelis stock costs EUR 12.80 on October 21, 2026, 5.67 percent below its high.

Results date and financial scale

Azelis is scheduled to report on October 22, 2026, after Jefferies projected third-quarter EBITA of EUR 108.0 million on October 12, 2026.
First-half 2026 revenue reached EUR 2.2 billion, up 3.20 percent year over year, while adjusted EBITDA rose 2.60 percent to EUR 233.0 million.
Azelis stock costs EUR 12.80 at Lang & Schwarz on October 21, 2026 at 3:16 p.m. CEST, 5.67 percent below the 52-week high of EUR 13.57.

Azelis, BE0974400328, Illustration mit AI erstellt.

Azelis is scheduled to report its next results on October 22, 2026, with the stock at EUR 12.80 at Lang & Schwarz on October 21, 2026 at 3:16 p.m. CEST. The company had generated EUR 2.2 billion of first-half revenue, up 3.20 percent year over year, according to the July 30, 2026 earnings transcript published by Yahoo Finance.

October 22 brings the next test

The reporting date is the immediate calendar marker for investors. The Asset reported on October 12, 2026 that Jefferies analyst David Kerstens expected third-quarter EBITA of EUR 108.0 million, 5.00 percent below consensus of EUR 113.4 million. The same report put full-year 2026 EBITA at EUR 424.4 million against consensus of EUR 436.0 million.

Price stays below the yearly high

The Lang & Schwarz quote of EUR 12.80 sits 5.67 percent below the 52-week high of EUR 13.57 and 86.05 percent above the 52-week low of EUR 6.88. The quoted market capitalization was EUR 3.1 billion, with a price-to-earnings ratio of 27.43 and a dividend yield of 2.00 percent as of October 21, 2026.

Margins and cash flow matter

Adjusted EBITDA reached EUR 233.0 million in the first half of 2026, up 2.60 percent from the prior-year period, while the adjusted EBITDA margin stood at 10.70 percent. Gross profit rose 4.30 percent to EUR 524.0 million, equal to a 24.20 percent margin, according to the earnings transcript.

The regional mix was uneven. First-half revenue in Asia Pacific increased 8.20 percent to EUR 428.0 million, while EMEA revenue grew 1.70 percent to EUR 990.0 million. Free cash flow was EUR 122.0 million, representing a 52.30 percent conversion rate, and net debt stood at EUR 1.6 billion at the end of June 2026.

What the figures leave investors watching

The October 22 update will put the projected third-quarter EBITA of EUR 108.0 million beside Azelis's first-half adjusted EBITDA growth of 2.60 percent. That comparison matters because the company entered the second half with stronger Asia Pacific growth but softer demand in parts of EMEA.

Stock position and company profile

Azelis distributes specialty chemicals and food ingredients across life sciences and industrial chemicals. Its shares are listed on Euronext Brussels under AZE.BR, and the group operates in the Basic Materials sector and Specialty Chemicals industry.

Azelis stock was trading at EUR 12.80 at Lang & Schwarz on October 21, 2026 at 3:16 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Azelis stock.